Azul de metileno, opción para la marcación de cáncer colorrectal pre procedimiento mínimamente invasivo. Reporte de caso

El cáncer colorrectal es una patología común que causa aproximadamente 861,000 muertes al año. Se presenta el caso de un paciente masculino de 50 años, con hipertensión arterial y Diabetes mellitus tipo II, con diagnóstico de neoplasia en colon descendente, al cual se le realizó procedimiento mínimamente invasivo, posterior a marcación tumoral con azul de metileno por medio de endoscopia de vías digestiva bajas. Postoperatorio adecuado, sin complicaciones. El tratamiento de elección para el cáncer colorrectal sin metástasis es la exeresis oncológica. Actualmente, el manejo quirúrgico recomendado es por medio de procedimiento mínimamente invasivo, sin embargo, es un desafío puesto que en algunos casos la identificación de la lesión es difícil y adicionalmente requiere una curva de aprendizaje pronunciada. Por lo anterior, utilizamos el azul de metileno para la marcación del tumor previo procedimiento, con excelentes resultados, sin complicaciones. La marcación tumoral con azul de metileno previa al procedimiento mínimamente invasivo es seguro, útil, económico y de bajo riesgo.

Colorectal cancer is a common pathology, causing approximately 861,000 deaths a year. The case a 50-year-old male patient, with arterial hypertension and type II diabetes mellitus, with a diagnosis of neoplasia in the descending colon, which was performed minimally invasive procedure, after tumor marking with methylene blue by means of endoscopy of lower digestive tracts. Adequate postoperative period, without complications. The treatment of choice for colorectal cancer without metastasis is oncological exeresis. Currently the recommended surgical management is by means of a minimally invasive procedure, however, it is a challenge since in some cases the identification of the lesion is difficult and additionally requires a pronounced learning curve. Therefore, we use methylene blue for the marking of the tumor after the procedure, with excellent results, without complications. Methylene blue tumor marking prior to the minimally invasive procedure is safe, useful, inexpensive, and low risk.

The effect of bariatric surgery on metabolic syndrome: A retrospective cohort study in Colombia.

Introduction and Objective: Metabolic syndrome (MetS) represents a group of metabolic abnormalities. It is currently a pandemic, and its prevalence is on the rise. MetS has a direct relationship with obesity, for this reason, bariatric and metabolic surgery has been proposed as a method to simultaneously control obesity and MetS. However, in Colombia the results of this intervention are unknown. This study aims to compare metabolic syndrome before and after bariatric surgery in a Colombian population. Methods: Retrospective cohort study conducted in a highly complex institution in Colombia, where comparing the prevalence of metabolic syndrome in patients who underwent bariatric surgery during a 1-year follow-up period, between January 2015 and December 2019. Of these patients, 48 underwent Roux-en-Y gastric bypass, and 32 underwent sleeve gastrectomy by laparoscopic technique. Results: A total of 80 patients were included, of which 67.5% were women and the mean age was 42.8 ± 12.9 years. The most frequent preprocedure comorbidities were arterial hypertension (36.2%), dyslipidemia (32.4%), and sleep apnea (20%). After bariatric surgery, the prevalence of metabolic syndrome decreased from 66.2% to 3.7% (p < 0.05). In addition, a reduction in the Homeostatic Model Assessment for Insulin Resistance score from 77.5% to 22.5% was observed during the follow-up period. HbA1c, creatinine, and thyroid-stimulating hormone, were the only parameters without significant changes. Conclusions: Metabolic and bariatric surgery is an effective treatment for weight reduction, with a high impact in reducing the prevalence of metabolic syndrome and insulin resistance in the short and medium term in the Colombian population.

Fístula colovesical secundaria a diverticulitis complicada: tratamiento laparoscópico. Reporte de caso / Colovesical fistula secondary to complicated diverticulitis, laparoscopic treatment. A case report

Resumen Introducción: La fístula colovesical es la unión entre la vejiga y el intestino grueso, se presenta en el 2% de los pacientes con enfermedad diverticular del colon, genera síntomas como neumaturia y fecaluria, asociados a infecciones urinarias recurrentes. Los pacientes se diagnostican mediante estudios imagenológicos y su tratamiento generalmente es quirúrgico. Objetivo: Reportar el caso de tratamiento laparoscópico de paciente con fístula colovesical secundaria a diverticulitis complicada. Caso clínico: Se presenta el caso de un paciente masculino de 69 años, con antecedente de enfermedad diverticular, cursando con infección de vías urinarias recurrentes, fecaluria y neumaturia. La cistoscopia no mostró trayecto fistuloso y la tomografía abdominopélvica mostró hallazgos inflamatorios y fístula colovesical asociada a diverticulitis complicada. Durante procedimiento laparoscópico se encuentra absceso pericólico sin evidencia del trayecto fistuloso, se realizó drenaje, sutura del colon e interposición del epiplón, sin resección intestinal. Paciente con adecuada evolución postoperatoria con egreso al sexto día. El objetivo del tratamiento quirúrgico se centra en el control de complicaciones generadas por los divertículos, en este caso, la fístula colovesical. Conclusiones: El procedimiento laparoscópico es de mínima invasión, no presenta la morbilidad que implica una resección de colon o una colostomía y se asocia con una recuperación funcional más rápida.

Abstract Introduction: The colovesical fistula is a junction between the urinary bladder and the large intestine. It occurs in 2% of patients with diverticular disease of the colon and generates symptoms such as pneumaturia and fecaluria associated with recurrent urinary tract infections. The patients are diagnosed by imaging studies and their treatment is usually surgical. Objective: To report the laparoscopic treatment administered to a patient that presented a case of colovesical fistula secondary to severe diverticulitis. Case report: The case of a 69-year-old male patient with a medical record of diverticular disease, who presented recurrent urinary tract infection, fecaluria, and pneumaturia is presented. The cystoscopy procedure showed no signs of anal fistula, and the abdominopelvic tomography showed signals of inflammations and colovesical fistula associated with complicated diverticulitis. During the laparoscopic procedure, a pericolic abscess was found without evidence of anal fistula. Drainage and suture of the colon and omentum interposition were performed without presenting intestinal resection. The patient had an adequate postoperative recovery and was discharged on the sixth day. The aim of this surgical treatment is focused on the control of medical complications caused by diverticulitis, in this case, colovesical fistula. Conclusions: This procedure is minimally invasive, and it is associated with a faster functional recovery since it does not present the morbidity of a colon resection or colostomy.

A step-by-step guide to creating an academic surgery interest group: Review article.

An academic interest group in medicine is defined as a collective that can be made up of undergraduate students, residents, and/or teachers, who share as an object of interest the advancement and growth of a specific area of medicine. It is organized to carry out extracurricular academic and research activities. It is essential to stimulate participation in these interest groups, which allow the personal and professional growth of their members, being a tool that promotes and provides better opportunities for entry as candidates for graduate studies. The American College of Surgeons is one of the largest medical scientific societies with the participation of undergraduate students with an interest in surgery. This society mentions the benefits of participating in interest groups in surgery, specifically, it highlights the importance of contributing to these when looking for a surgical specialty, because they address issues such as: what is the mentioned specialty itself?, what are the details about the application process for each surgical specialty?, these groups can provide information on different residency programs, lifestyle benefits, and/or cons; in addition to improving practical skills through surgical technique workshops or various organized activities. Based on the above, the objective of this manuscript is to design a Step-by-step guide for the creation of a surgical interest group, in order to encourage participation by medical students, residents, and teachers in the research and academic field.

Síndrome de Mirizzi tipo V: Manejo laparoscópico / Mirizzi syndrome type V: laparoscopic management

Resumen Introducción: El Síndrome de Mirizzi es una complicación infrecuente de la enfermedad litiásica biliar, con una incidencia menor al 1% en países desarrollados, puede desarrollarse en cinco variantes, siendo menos frecuente la variante tipo V. La literatura actual discrepa sobre el manejo de esta condición, afirmando que la cirugía laparoscópica no es segura como procedimiento estándar. Caso Clínico: Se presenta el caso de Síndrome de Mirizzi en un hombre de 80 años, que es remitido al departamento de urgencias por sospecha de sepsis de origen abdominal, con estudio ecográfico de colelitiasis, neumobilia y dilatación de las vías biliares. Se realizó Colangiopancreatografía retrógrada endoscópica con imposibilidad técnica para la movilización y extracción de los cálculos por gran tamaño, recurriéndose a exploración a través de técnica laparoscópica, obteniéndose resultados satisfactorios. Conclusión: Para tratar el Síndrome de Mirizzi, es necesario considerar las características del paciente y la experiencia del cirujano ya que ambos factores influyen directamente en la modalidad del tratamiento, sus complicaciones y tasas de éxito. En el presente caso, la experiencia del autor principal en el manejo de procedimientos mínimamente invasivos y la consideración de reducir el riesgo de complicaciones como infecciones en un paciente frágil, fueron los factores que influyeron para la decisión de intervención laparoscópica.

Abstract Introduction: Mirizzi's syndrome is an infrequent complication of biliary lithiasic disease, with an incidence of less than 1% in developed countries, being even less frequent the type V variant. Current literature disagrees on the management of this condition, stating that laparoscopic surgery is not safe as a standard procedure. Clinical Case: We present the case of Mirizzi's Syndrome in an 80-year-old man, which is referred to the emergency department for suspicion of sepsis of abdominal origin, with ultrasound study of cholelithiasis, pneumoobilia and dilation of the bile ducts. Retrograde endoscopic cholangiopancreatography was performed with technical impossibility for the mobilization and extraction of large-size stones, resorting to exploration through laparoscopic technique, obtaining satisfactory results. Conclusion: It is necessary to emphasize that the type of Mirizzi syndrome, the patient's characteristics and the surgeon's experience directly influence the treatment modality, its complications and/or success rates. In the present case, the experience of the main author in the management of minimally invasive procedures and the consideration of reducing the risk of complications such as infections in a fragile patient, were the factors that influenced the decision for laparoscopic intervention.

La práctica de la academia y la cirugía en tiempos del Covid-19 / The practice of academia and surgery in times of Covid-19 / A prática da academia e da cirurgia nos tempos do Covid-19

El 2020 será un año para recordar en todos los aspectos. Escribo estas letras con el fin de evaluar lo que ha sido el desarrollo de la profesión y lo que esperamos de ella durante estos tiempos. Iniciamos con gran optimismo el año 2020, con el desarrollo del programa de posgrado en cirugía general en nuestra universidad, el cual es un proyecto ambicioso que tiene la misión, desde el inicio, de lograr el posicionamiento como un programa abanderado, basado en la experiencia y el desarrollo de la ciencia que nos da el transitar en medios académicos por más de 30 años. Pero el verdadero motor para llevar a cabo este proyecto ha sido los mismos estudiantes, quienes hoy, agrupados bajo la modalidad de Semillero de Investigación, han generado diferentes compromisos académicos con los docentes y con la universidad. Además, la tecnología que nos aporta nuestro gran aliado en salud, la Fundación Oftalmológica de Santander Clínica Ardila Lülle - FOSCAL, así como el humanismo que nos ha acompañado durante todo este periodo, generará en nuestros usuarios una indescriptible sensación de seguridad y confianza en sus médicos.

2020 will be a year to remember in all aspects. I write these letters in order to evaluate what has been the development of the profession and what we expect from it during these times. We started 2020 with great optimism, with the development of the postgraduate program in general surgery at our university, which is an ambitious project that has the mission, from the beginning, to achieve positioning as a flagship program, based on experience and the development of science that has given us traveling in academic circles for more than 30 years. But the true engine to carry out this project has been the students themselves, who today, grouped under the Research Seedbed modality, have generated different academic commitments with teachers and with the university. In addition, the technology provided by our great ally in health, the Fundación Oftalmológica de Santander Clínica Ardila Lülle - FOSCAL as well as the humanism that has accompanied us throughout this period, will generate in our users an indescribable sense of security and trust in their doctors.

2020 será um ano para ser lembrado em todos os aspectos. Venho avaliar como tem sido o desenvolvimento da profissão e o que esperamos dela nestes tempos. Iniciamos 2020 com muito otimismo, com o desenvolvimento do programa de pós-graduação em cirurgia geral da nossa universidade.Um projeto ambicioso que teve como missão, desde o início, alcançar o posicionamento de um programa reconhecido, com base na experiência e no desenvolvimento da ciência que nos permitiu pesquisar em círculos acadêmicos por mais de 30 anos. Mas o verdadeiro motor para a realização deste projeto têm sido os próprios alunos, que hoje, agrupados na modalidade de grupos de pesquisa , geram diversos compromissos acadêmicos com os professores e com a universidade. Além disso, a tecnologia disponibilizada pelo nosso grande aliado na área da saúde, a Fundación Oftalmológica de Santander Clínica Ardila Lülle - FOSCAL, bem como o humanismo que nos acompanhou ao longo deste período, irão gerar em nossos usuários um indescritível sentimento de segurança e confiança em seus médicos

Hemicolectomía radical laparoscópica: opción de mínima invasión para el cáncer de colon / Laparoscopic radical hemicolectomy: minimally invasive option for colon cancer / Hemicolectomia radical laparoscópica: opcão minimamente invasiva para cãncer de cólon

Introducción. El cáncer de colon es una de las principales causas de morbimortalidad a nivel mundial. En Colombia se presentan cerca de 145,600 casos nuevos al año. Cada vez son más los reportes de este tipo de patologías intervenidas por vía laparoscópica, aunque son pocos en Colombia. El objetivo de este artículo es mostrar el abordaje de esta patología mediante un procedimiento mínimamente invasivo: la colectomía derecha por vía laparoscópica, el cual es poco utilizado en el país. Caso clínico. Paciente de 86 años que consulta por pérdida de peso, adinamia y dolor abdominal en flanco derecho. Presenta además anemia ferropénica y sangre oculta en materia fecal. Las endoscopias digestivas muestran lesión ulcerada vegetante de aspecto neoplásico a nivel del ciego. La biopsia revela adenocarcinoma infiltrante moderadamente diferenciado con áreas de necrosis. Se realiza una colectomía derecha por técnica laparoscópica. Se hace seguimiento con neoadyuvancia por parte de Oncología Clínica. Discusión. El adenocarcinoma es uno de los cánceres primarios más comunes en el colon. La resección quirúrgica es una excelente alternativa para el manejo y tratamiento de estos tumores. En Colombia, la mayoría de estas resecciones se realizan por vía abierta. La resección por vía laparoscópica es un método que demuestra similar eficacia, ofreciendo una disminución en la respuesta inflamatoria, con mejor control del dolor y limitaciones funcionales. Conclusiones. La colectomía por vía laparoscópica para resección de tumores de colon es un método seguro, eficaz y reproducible. Sin embargo, exige tecnología de alto costo y debe ser realizada por un grupo quirúrgico con habilidad y experiencia en sutura manual laparoscópica. Cómo citar: López-Gómez LE, Dominguez ­ Alvarado GA, D ́vera Camargo D, Lozano-Eslava LA, Martínez-Rojas PA. Hemicolectomía radical laparoscópica: opción de mínima invasión para el cáncer de colon. MedUNAB. 2020;23(2): 281-287. doi: 10.29375/01237047.3829

Introduction. Colon cancer is one of the main causes of morbimortality in the world. Colombia counts near 145,600 new cases per year. The reports of laparoscopic intervention in this pathology are growing, but in Colombia there is little recent work on the matter. The aim of this article is to show how this pathology can be addressed through a minimally invasive procedure, laparoscopic right colectomy, which is not frequently used in the country. Clinical case. An 86-year-old patient consults due to weight loss, adynamia and abdominal pain on right side. Iron-deficiency anemia and hidden blood in feces was reported. The digestive endoscopies show the presence of a vegetant and ulcerated lesion of neoplastic appearance in the cecum. A biopsy revealed a moderately differentiated, invasive adenocarcinoma with areas of necrosis. A laparoscopic right colectomy is conducted. Definitive report of moderately differentiated and ulcerated, invasive, mucinous adenocarcinoma, with lesion up to the serous membrane. Follow up is conducted with neoadjuvant therapy by the Clinical Oncology service. Discussion. Adenocarcinoma is one of the most common primary cancers in the colon. Surgical still an excellent alternative for the management of this kind of tumor. In Colombia, the majority of these resections are carried out by open surgery. However, laparoscopic resection is a method that offers similar outcomes to the traditional procedure, while providing a reduction in the inflammatory response, with better pain control and control of functional limitations. Conclusions. Laparoscopic colectomy for the resection of colonic tumors is a safe, effective and reproducible method. However, it requires high-cost technology and it must be conducted by a surgical team skilled and experienced in manual laparoscopic suturing.Cómo citar: López-Gómez LE, Dominguez ­ Alvarado GA, D ́vera Camargo D, Lozano-Eslava LA, Martínez-Rojas PA. Hemicolectomía radical laparoscópica: opción de mínima invasión para el cáncer de colon. MedUNAB. 2020;23(2): 281-287. doi: 10.29375/01237047.3829

Introdução. O câncer de cólon é uma das principais causas de morbimortalidade em todo o mundo. Na Colômbia, há uma incidência aproximada de 145,600 casos novos por ano. Na Colômbia existam poucos trabalhos recentes sobre este tipo de procedimentos. O objetivo deste artigo é mostrar a abordagem de o adenocarcinoma de cólon, através de um procedimento minimamente invasivo: a colectomia direita pela via laparoscópica, pouco utilizada no país. Caso clínico. Paciente de 86 anos que apresenta perda de peso, adinamia e dor abdominal no flanco direito, anemia ferropriva e sangue oculto nas fezes. As endoscopias digestivas evidenciam a presença de uma lesão ulcerada vegetante com aparência neoplásica no nível do ceco. A biópsia revelou adenocarcinoma infiltrante moderadamente diferenciado com áreas de necrose. As imagens de extensão mostram um efeito de massa intraluminal ao nível do ceco com adenomegalia pericecal. Realizou-se uma colectomia direita laparoscópica. Relato definitivo de adenocarcinoma mucinoso infiltrante moderadamente diferenciado e ulcerado, com comprometimento da serosa. O serviço de Oncologia Clínica fez o acompanhamento neoadjuvante. Discussão. O adenocarcinoma é um dos cânceres primários mais comuns no cólon. A ressecção cirúrgica continua sendo uma excelente alternativa para a gestão e tratamento deste tipo de tumores. Na Colômbia, a maioria dessas ressecções é realizada pela via aberta. A ressecção pela via laparoscópica é um método que oferece ressecções semelhantes às do procedimento tradicional, apresentando diminuição da resposta inflamatória, com melhor controle da dor e das limitações funcionais. Conclusão. A colectomia pela via laparoscópica para ressecção de tumores de cólon é um método seguro, eficaz e reprodutível. No entanto, requer tecnologia de alto custo e deve ser realizada por um grupo cirúrgico com habilidade e experiência em sutura manual laparoscópica. Cómo citar: López-Gómez LE, Dominguez ­ Alvarado GA, D ́vera Camargo D, Lozano-Eslava LA, Martínez-Rojas PA. Hemicolectomía radical laparoscópica: opción de mínima invasión para el cáncer de colon. MedUNAB. 2020;23(2): 281-287. doi: 10.29375/01237047.3829

Cardio-Metabolic Health Venezuelan Study (EVESCAM): Design and Implementation / Estudio Venezolano de Salud Cardio-Metabólica (EVESCAM): Diseño e Implementación

The EVESCAM (EstudioVenezolano de Salud Cardio-Metabólica) is the first national, population survey in Venezuela, designed to examine the prevalence of diabetes and cardio-metabolic risk factors and its relationship with lifestyle. It is a cross-sectional, cluster sampling study, which recruited 4454 participants aged ≥ 20 years. The data were collected in community health-care centers by trained health professionals and medical students. The data collected from each subject included, after informed consent, structured questionnaires (clinical, demographic, physical activity, nutritional and psychological), anthropometric measurements (weight, height and waist circumference), body fat by bioelectrical impedance, hand grip, blood pressure, electrocardiogram, and biochemical measurements (standard 75 g oral glucose tolerance test, total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides). The data will be used to estimate the prevalence of overweight, obesity, prediabetes, diabetes, hypertension, dyslipidemias, sarcopenia and metabolic syndrome; and to examine their relationships with lifestyle factors. The risk of coronary heart disease and impaired glucose regulation will be estimated using the Framingham Coronary Heart Disease Risk Score and the Latin America adaptation of the Finnish Diabetes Risk Score (LA-FINDRISC), respectively. These results will guide national cardiovascular and diabetes prevention strategies, and will be available for government agencies to help in the implementation of public health policies.

El EVESCAM (Estudio Venezolano de Salud Cardio-Metabólica) es el primer estudio poblacional de muestreo nacional en Venezuela diseñado para examinar la prevalencia de diabetes y factores de riesgo cardio-metabólico, y su relación con el estilo de vida. Se trata de un estudio transversal de muestreo por conglomerados, reclutando 4454 participantes de 20 años o más. Los datos fueron recogidos en centros de salud de la comunidad por profesionales de salud y estudiantes de medicina entrenados. Después del consentimiento infor mado, los datos recolectados en cada sujeto incluyeron: cuestionarios estructurados (clínico, demográfico, actividad física, nutricional y psicológico), medidas antropométricas (peso, talla y circunferencia de cintura), grasa corporal por impedancia bioeléctrica, fuerza de aprehensión de la mano, presión arterial, electrocardiograma y medidas bioquímicas (prueba de tolerancia a la glucosa oral estándar con 75 g de glucosa, colesterol total, colesterol HDL, colesterol LDL y triglicéridos). Los datos se utilizarán para estimar la prevalencia de sobrepeso, obesidad, prediabetes, diabetes, hipertensión arterial, dislipidemias, sarcopenia y síndrome metabólico; y para examinar sus relaciones con factores de estilo de vida. El riesgo de cardiopatía coronaria y de alteración de la regulación de la glucosa se calculará utilizando la puntuación de riesgo de la enfermedad coronaria de Framingham y la adaptación para Latinoamérica de la puntuación finlandesa del riesgo de diabetes (LA-FINDRISC), respectivamente. Estos resultados guiarán las estrategias nacionales de prevención cardiovascular y diabetes, y estarán disponibles para que las agencias gubernamentales ayuden en la implementación de las políticas de salud pública.

Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group.

BACKGROUND: Gemcitabine and erlotinib have shown a survival benefit in the first-line setting in metastatic pancreatic cancer (mPC). The aim of this study was to assess whether combining capecitabine (C) with gemcitabine + erlotinib (GE) was safe and effective versus GE in patients with mPC. PATIENTS AND METHODS: Previously untreated mPC patients were randomised to receive G (1000 mg/m2, days 1, 8, 15) + E (100 mg/day, days 1-28) + C (1660 mg/m2, days 1-21) or GE, q4 weeks, until progression or unacceptable toxicity. Primary end-point: progression-free survival (PFS); secondary end-points: overall survival (OS), response rate, relationship of rash with PFS/OS and safety. RESULTS: 120 patients were randomised, median age 63 years, ECOG status 0/1/2 33%/58%/8%; median follow-up 16.5 months. Median PFS in the gemcitabine-erlotinib-capecitabine (GEC) and GE arms was 4.3 and 3.8 months, respectively (hazard ratio [HR]: 0.88, 95% confidence interval [CI]: 0.58-1.31; p = 0.52). Median OS in the GEC and GE arms was 6.8 and 7.7 months, respectively (HR: 1.09, 95% CI: 0.72-1.63; p = 0.69). Grade 3/4 neutropenia (GEC 43% versus GE 15%; p = 0.0008) and mucositis (GEC 9% versus GE 0%; p = 0.03) were the only statistically significant differences in grade 3/4 adverse events. PFS and OS were significantly longer in patients with rash (grade ≥1) versus no rash (grade = 0): PFS 5.5 versus 2.0 months (HR = 0.39, 95% CI: 0.26-0.6; p < 0.0001) and OS: 9.5 versus 4.0 months (HR = 0.51, 95% CI: 0.33-0.77; p = 0.0014). CONCLUSION: PFS with GEC was not significantly different to that with GE in patients with mPC. Skin rash strongly predicted erlotinib efficacy. The study was registered with ClinicalTrials.gov: NCT01303029.

Cardio-Metabolic Health Venezuelan Study (EVESCAM): Design and Implementation.

The EVESCAM (EstudioVenezolano de Salud Cardio-Metabólica) is the first national, population survey in Venezuela, designed to examine the prevalence of diabetes and cardio-metabolic risk factors and its relationship with lifestyle. It is a cross-sectional, cluster sampling study, which recruited 4454 participants aged ≥ 20 years. The data were collected in community health-care centers by trained health professionals and medical students. The data collected from each subject included, after informed consent, structured questionnaires (clinical, demographic, physical activity, nutritional and psychological), anthropometric measurements (weight, height and waist circumference), body fat by bioelectrical impedance, hand grip, blood pressure, electrocardiogram, and biochemical measurements (standard 75 g oral glucose tolerance test, total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides). The data will be used to estimate the prevalence of overweight, obesity, prediabetes, diabetes, hypertension, dyslipidemias, sarcopenia and metabolic syndrome; and to examine their relationships with lifestyle factors. The risk of coronary heart disease and impaired glucose regulation will be estimated using the Framingham Coronary Heart Disease Risk Score and the Latin America adaptation of the Finnish Diabetes Risk Score (LA-FINDRISC), respectively. These results will guide national cardiovascular and diabetes prevention strategies, and will be available for government agencies to help in the implementation of public health policies.

Long-term complication in follicular lymphoma: assessing the risk of secondary neoplasm in 242 patients treated or not with 90-yttrium-ibritumomab-tiuxetan.

BACKGROUND: Non-Hodgkin lymphoma patients have a 25% increased risk of secondary primary neoplasms (SPNs). Regarding the controversy about the increased risk of SPN in patients exposed to radioimmunotherapy (RIT), we have analyzed this issue in a cohort of follicular lymphoma (FL) patients treated with/without RIT. PATIENTS AND METHODS: A retrospective study including all consecutive FL patients diagnosed since 2001 was performed. Demographic, clinical data including the incidence of any kind of neoplasm (excluding basocellular skin carcinoma) were recorded. RESULTS: A total of 242 patients were registered, male/female: 103/139, mean age: 59.9 yr (15-86), stage IV (57.8%), and Follicular Lymphoma Prognostic Index (FLIPI) low-risk (62.15%) predominance. Ninety-six patients (39.7%) were treated with 90Y-IT. The median follow-up for patients treated or not with 90Y-IT was 61 (8-273) and 38 (1-171) months. With respect to SPN incidence, 38 (15.6%) patients have at least two cancers, in 17 (44.7%), FL was the SPN; for the rest (226), the global incidence of SPNs was 9.3% (21), but there were no differences related to the exposition or not to 90Y-IT (P = 0.26). In seven patients, more than two (2-6) different therapies were registered; four were exposed to fludarabine-based therapy, three to radiotherapy and two to autologous stem-cell transplantation, and in the RIT cohort, two patients developed myelodysplastic syndrome. CONCLUSION: This is one of the largest single institution reports assessing the risk of SPN in FL patients treated (96) or not (146) with 90Y-IT. It seems that 90Y-IT does not increase significantly the risk of SPN but avoiding its use after fludarabine and other intense cytotoxic schemes is recommended.

Patients Older Than 65 Years With Non-Hodgkin Lymphoma Are Suitable for Treatment With (90)Yttrium-Ibritumumab Tiuxetan: A Single-Institution Experience.

BACKGROUND: The mean age of patients included in clinical trials does not reflect the current clinical practice for patients with B-cell non-Hodgkin lymphoma (B-NHL). We compared our outcomes for patients with B-NHL aged < 65 and > 65 years who were treated with 90-yttrium-ibritumomab tiuxetan therapy ((90)Y-IT). PATIENTS AND METHODS: A total of 108 patients who had received (90)Y-IT according to the hospital protocol (ISCRTN36210045) were eligible. A quality of life (QoL) assessment using the Medical Outcomes Study short form 36-item survey was performed for patients aged > 65 years. RESULTS: Of the 108 patients, 43 were aged > 65 years (mean age, 73.4 years; men 46.15%); 37 had follicular NHL (86.0%). Also, 27 patients had previously undergone < 2 therapy regimens (62.8%). The mean follow-up period was 45.2 months. The mean progression-free survival (PFS) period was 71.3 months, and the mean overall survival was 78.2 months. The median values were not reached. The overall response rate was 90.5%, and a complete response was observed in 36 of the 43 patients aged > 65 years (85.7%). Neutropenia (43.3%) and thrombocytopenia (45.2%) were the most frequent grade 3 and 4 toxicities. Five patients required a red blood cell transfusion and 11, a platelet transfusion. Five patients aged > 65 years (11.6%) developed a second tumor. These outcomes were similar to those for the younger patients. The QoL assessment showed scores similar to those of general population for general health and social functioning. CONCLUSION: This is the largest cohort of NHL treated with RIT in a single institution in Spain. We observed a high response rate and prolonged PFS in patients with B-NHL, independent of patient age. Thus, consolidation RIT offers better outcomes with manageable toxicity.

Estudio venezolano de salud cardiometabólica (EVESCAM): descripción general y muestreo / Venezuelan cardiometabolic health study (EVESCAM): overview and sampling

El Estudio Venezolano de Salud Cardio-Metabólica (EVESCAM) es el primer estudio multicéntrico sobre la Salud cardiometabólica del venezolano. Evaluar la prevalencia de diabetes y Factores de Riesgo Cardio-Metabólico (FRCM), y su relación con el estilo de vida en Venezuela. Es un estudio poblacional, transversal, con muestreo por conglomerados, cuyo objetivo es evaluar a 4200 participantes ≥ 20 años de las 8 regiones de Venezuela. Los datos serán recolectados en centros asistenciales por profesionales de la salud y estudiantes de medicina previamente capacitados y certificados. Después de obtener el consentimiento informado, en cada participante se realizarán: a. Cuestionarios estructurados para obtener datos clínicos, demográficos, de actividad física, nutricionales, psicológicos y estratos sociales; b. examen físico (peso, talla, grasa corporal por bioimpedancia, circunferencia de la cintura, fuerza de aprehensión de la mano, presión arterial y electrocardiograma) y c. Pruebas bioquímicas (Prueba de Tolerancia a la Glucosa -PTGO- estándar 75 g, colesterol total, HDL-colesterol, LDL-colesterol y triglicéridos). Además se calculará el riesgo de enfermedad cardíaca coronaria (por puntaje de Framingham) y la regulación de la glucosa alterada (por puntaje FINDRISC modificado). Se estimará la prevalencia de sobrepeso, obesidad, prediabetes, diabetes, hipertensión, dislipidemias, sarcopenia, síndrome metabólico y su relación con los factores de estilo de vida (nutrición, actividad física, estrés psicosocial, uso de tabaco y alcohol). En esta primera parte se explica la metodología y la aplicación del muestreo a la Ciudad de Barquisimeto.

This is the first cardiometabolic multicentric study of the Venezuelan people cardiometabolic health. To evaluate the relationship of the prevalence of diabetes and risk factors with Venezuelan lifestyle. This is a population, transverse, with conglomerates of 4200 of 20 or more years-old in 8 areas of Venezuela. Data were colected in different health centers by physicians and medical students, who had been enabled for this. After obtaining consented inform, to each participant the following was applied: 1) structured questionaires for clinical data, demography, physical activity, nutrition, psicological traits and social status. 2. complete physical examination, including EKG). 3. Glucose tolerance test, lipid profile, Framingham score and FINDRISK modified score. Prevalence of overweight, obesity, prediabetes, hypertension, dyslipidemia, sarcopenia, metabolic syndrome and their relationship with lifestyle factors. This is the first parte in the city of Barquisimeto.

Long-term efficacy of (90)Y ibritumomab tiuxetan therapy in follicular non-Hodgkin lymphoma and health-related quality of life.

The aim of this study was to analyze the outcomes of 37 follicular lymphoma (FL) patients treated with (90)ytrium ibritumomab tiuxetan (90Y-IT), outside of clinical trial, according to protocol ISCRTN36210045, after ≥5 years follow-up to February 2014. Health-related quality of life (HRQoL) was evaluated with the SF-36, Spanish version, and compared with the general population of Spain. Patients had a mean age of 61.9 (range, 30-85) years and included 18 males. FLIPI, low: 25 (67.6 %), intermedium 9 (24.3 %), and low 3 (8.1 %). Previous therapy schedules >2: 48.6 % The median follow-up was 66 months, mean Time to Relapse (TTR) 71.3 months (58.8-83.8) median not reached. Thirty-four patients achieved complete response (91.8 %), and three no response. Mean overall survival: 82.3 months (71.6-92.9). Four patients presented with concomitant tumors (colon, breast, prostate, lung) after radioimmunotherapy, and three developed second primary neoplasms (esophagus, renal, and myelodysplastic syndrome in a relapsed patient who received fludarabine). Four of 10 deaths were related to lymphoma progression. Hematological toxicities were mild and easily managed. No patients required hospitalization. Negative scores were obtained in the physical and emotional roles items; however, the perception of general health and vitality were better than in the general population, with the best outcomes in non-relapsed patients. Radioimmunotherapy with 90Y-IT was safe and effective as long-term therapy in patients with FL. Early use of radioimmunotherapy could offer good, sustained responses with low toxicity over the long term and acceptable HRQoL.

Complicaciones mecánicas del infarto: rotura de pared libre ventricular. Presentación de un caso / Mechanical complications of myocardial infarction: ventricular free wall rupture. Report of a case

En los pacientes con síndrome coronario agudo, dos terceras partes de los casos fallece sin alcanzar a recibir atención hospitalaria (principalmente en las primeras dos horas) debido a la muerte súbita. Del tercio restante, el 50% lo hará en las 24 horas siguientes a su ingreso hospitalario, principalmente debido a las complicaciones mecánicas del infarto. Actualmente, la identificación y estratificación inmediata del paciente con síndrome coronario agudo, el papel de las unidades coronarias y la reperfusión temprana (farmacológica o mecánica) en los casos indicados, han demostrado disminuir la morbimortalidad por cardiopatía isquémica. Dentro de las complicaciones mecánicas del infarto, la ruptura de pared libre ventricular se presenta en el 5-10% de los pacientes hospitalizados que fallecen por infarto agudo del miocardio con elevación del segmento ST. Se presenta un caso clínico con estas características.

In patients with acute coronary ischemic syndrome, two-thirds of cases die without reaching hospital care (mainly in the first two hours) due to sudden death. Of the remaining third, 50% will do so within 24 hours of hospital admission, mainly due to mechanical complications of infarction. Currently, the identification and early stratification, the role of coronary care units and early reperfusion (pharmacologic or mechanical) where indicated, have been shown to decrease morbidity and mortality from ischemic heart disease. Within the mechanical complications of infarction, ventricular free wall rupture occurs in 5-10% of hospitalized patients dying of acute myocardial infarction with ST segment elevation. We report a case with these features.

Mediastinal extravasation of doxorubicin.

A 48-year-old woman with a diagnosis of breast carcinoma was treated with adjuvant chemotherapy through a central venous catheter with subcutaneous reservoir (Port-A-Cath). While doxorubicin was administered, the patient presented thoracic pain and breathing distress due to superior vena cava perforation by the central catheter and subsequent extravasation of the drug into the mediastinum. The patient recovered without sequelae with conservative therapy. Cytostatic extravasation via central catheter is an uncommon complication in clinical practice. In this paper we present the first doxorubicin extravasation through a central catheter in adults and review the only ten cases found in the literature.